Fujifilm‘s (TSE:4901) SonoSite subsidiary said earlier this week it appointed Fujifilm vet and current Fujifilm Medical Systems USA and Fujifilm New Development USA prez Takaaki Ueda as its new chair and CEO.

Previously, Ueda has also served as Fujifilm global endoscopy systems division GM, the company said. Ueda will replace the departing Masayuki Higuchi who is returning to Tokyo to take the role of Fujifilm global finance & accounting deputy GM.

Alongside the appointment, the company said it also promoted Rich Fabian to the position of prez and COO. Fabian had previously held various executive positions for 15 years with Royal Philips (NYSE:PHG).

“On behalf of all employees at Fujifilm SonoSite Inc., we are grateful to Mr. Higuchi’s contributions to the business and wish him success in his important new role. Looking toward the future, I am pleased to welcome Rich Fabian’s promotion to president and chief operating officer — his wealth of experience in sales, service, distribution, supply chain and manufacturing will be crucial to constant innovation of point-of-care ultrasound technology and improving patient lives,” Ueda said in a press release.

 Biolase appoints board member Norbe as prez & CEO

Biolase (NSDQ:BIOL) said yesterday it named dental industry vet and board member Todd Norbe as its new prez & CEO.

Norbe previously served as prez of Danaher‘s (NYSE:DHR) subsidiary KaVo Kerr, and held the position of VP and GM of Metrex Medical – Sybron Dental Specialties prior to and after its acquisition by Danaher in 2006.

“I look forward to working with the Biolase team to advance dentistry that will benefit both the patient and our valued customer, the dentist,” Norbe said in a press release.

The Irvine, Calif.-based company also said it appointed former interim CEO John Beaver as its new SVP and CFO.

“We are very excited and fortunate to have Todd step in as CEO and believe his willingness to do that, given his vantage point as a board member, demonstrates his bullishness on the future of lasers in dentistry and Biolase. In the short time that he has been on the Biolase Board, he has been a key contributor to the vision and strategy of the company. Todd is a true leader with excellent management skills and an exceptional record of accomplishment in the global dental market,” board chair Dr. Jonathan Lord said in a press release. “We are confident that Todd and John, along with our newly-constituted board of directors, represent a very strong and experienced leadership team. This group has proven leadership in the dental industry and in driving the adoption of innovation in clinical practice. Minimally invasive laser dentistry is the future of the dental industry, especially in growing areas like pediatric care and implant periodontitis. Our team is focused on expanding the adoption of our all-tissue lasers throughout the dental industry. John’s effort this quarter was fantastic, and it shows in the results, particularly in the traction we are gaining in our Southern California-focused sales, marketing and training initiative. We are seeing significant increases in both adoption and utilization of all-tissue lasers. Building revenue through the sale of more lasers and recurrent revenue through consumables, is our goal.”

Read more

 Tactile Systems names Moen as new CFO

Tactile Systems Technology said this week it named Brent Moen as its new CFO, replacing Lynn Blake who is resigning from the role as of September 1 for personal reasons.

Moen previously served as CFO at Entellus Medical, and held other CFO and administrative positions at a variety of businesses prior to that. Blake is slated to stay on in an advisory role to the company through to March 2019.

“I’m very pleased to announce Brent’s appointment and welcome him to Tactile Medical. Brent possesses a strong financial background, with over 20 years of management level experience including senior leadership roles as Chief Financial Officer of two publicly traded companies, most recently in the medical device industry at Entellus Medical. I look forward to his strategic insight and future contributions as a member of the executive leadership team as we continue to scale our business. I would also like to thank Lynn for the valuable contributions she has made since joining Tactile Medical in April 2016. Her leadership and expertise helped Tactile Medical complete our IPO, successfully transition to the public markets and support Tactile Medical’s subsequent growth and expansion of our shareholder base,” CEO Gerald Mattys said in a prepared statement.

“Tactile Medical is an impressive organization that has developed a clear leadership position in the treatment of lymphedema and established a consistent track record of impressive growth and execution. I am excited to join the team and am committed to leading the Company through its next stage of growth,” Moen said in a press release.

Read more

 Johnson & Johnson lifts DelOrefice to new role as investor relations VP

Johnson & Johnson (NYSE:JNJ) said yesterday it lifted Chris DelOrefice to the new role of investor relations VP, reporting to CFO Joseph Wolk.

DelOrefice has worked with Johnson & Johnson for 19 years, previously serving as NA hospital medical devices biz CFO, the company said.

“Chris is an accomplished leader, with a long track record of success. He consistently demonstrates Credo values and will continue to have a positive impact on Johnson & Johnson’s financial strength and stability and on the development of our future business leaders,” Wolk said in a press release.

Read more

 PositiveID prez Probst resigns

PositiveID (OTC:PSID) said in an SEC filing posted late last month that its president Lyle Probst has resigned, effective immediately.

The Delray Beach, Fla.-based company has not yet commented on the resignation or if it is searching for a replacement for the departing president.

Read more

• Haemonetics taps Llorens as global manufacturing, supply chain SVP
• Carmat appoints former LivaNova vet Dupoux as QA senior director
• Ortho Consulting group adds Dubowski as Int’l biz dev head
• Neurologics names former NFL exec Austin to sports division prize

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW